Suppr超能文献

完整细胞上肿瘤坏死因子受体超家族(TNFRSF)受体的结合研究

Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

作者信息

Lang Isabell, Füllsack Simone, Wyzgol Agnes, Fick Andrea, Trebing Johannes, Arana José Antonio Carmona, Schäfer Viktoria, Weisenberger Daniela, Wajant Harald

机构信息

From the Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Röntgenring 11, 97070 Würzburg, Germany.

From the Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Röntgenring 11, 97070 Würzburg, Germany

出版信息

J Biol Chem. 2016 Mar 4;291(10):5022-37. doi: 10.1074/jbc.M115.683946. Epub 2015 Dec 31.

Abstract

Ligands of the tumor necrosis factor superfamily (TNFSF) interact with members of the TNF receptor superfamily (TNFRSF). TNFSF ligand-TNFRSF receptor interactions have been intensively evaluated by many groups. The affinities of TNFSF ligand-TNFRSF receptor interactions are highly dependent on the oligomerization state of the receptor, and cellular factors (e.g. actin cytoskeleton and lipid rafts) influence the assembly of ligand-receptor complexes, too. Binding studies on TNFSF ligand-TNFRSF receptor interactions were typically performed using cell-free assays with recombinant fusion proteins that contain varying numbers of TNFRSF ectodomains. It is therefore not surprising that affinities determined for an individual TNFSF ligand-TNFRSF interaction differ sometimes by several orders of magnitude and often do not reflect the ligand activity observed in cellular assays. To overcome the intrinsic limitations of cell-free binding studies and usage of recombinant receptor domains, we performed comprehensive binding studies with Gaussia princeps luciferase TNFSF ligand fusion proteins for cell-bound TNFRSF members on intact cells at 37 °C. The affinities of the TNFSF ligand G. princeps luciferase-fusion proteins ranged between 0.01 and 19 nm and offer the currently most comprehensive and best suited panel of affinities for in silico studies of ligand-receptor systems of the TNF family.

摘要

肿瘤坏死因子超家族(TNFSF)的配体与肿瘤坏死因子受体超家族(TNFRSF)的成员相互作用。许多研究小组对TNFSF配体与TNFRSF受体之间的相互作用进行了深入评估。TNFSF配体与TNFRSF受体相互作用的亲和力高度依赖于受体的寡聚化状态,并且细胞因子(如肌动蛋白细胞骨架和脂筏)也会影响配体-受体复合物的组装。关于TNFSF配体与TNFRSF受体相互作用的结合研究通常使用含有不同数量TNFRSF胞外域的重组融合蛋白进行无细胞检测。因此,对于单个TNFSF配体与TNFRSF相互作用所测定的亲和力有时相差几个数量级,并且常常不能反映在细胞检测中观察到的配体活性,这并不奇怪。为了克服无细胞结合研究和重组受体结构域使用的固有局限性,我们在37℃下对完整细胞上与细胞结合的TNFRSF成员进行了用高斯王子荧光素酶TNFSF配体融合蛋白的全面结合研究。TNFSF配体高斯王子荧光素酶融合蛋白的亲和力范围在0.01至19纳米之间,为TNF家族配体-受体系统的计算机模拟研究提供了目前最全面且最适合的亲和力数据集。

相似文献

1
Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.
J Biol Chem. 2016 Mar 4;291(10):5022-37. doi: 10.1074/jbc.M115.683946. Epub 2015 Dec 31.
3
A co-evolution perspective of the TNFSF and TNFRSF families in the immune system.
Trends Immunol. 2003 Jul;24(7):387-94. doi: 10.1016/s1471-4906(03)00166-2.
4
Computational analyses of the interactome between TNF and TNFR superfamilies.
Comput Biol Chem. 2023 Apr;103:107823. doi: 10.1016/j.compbiolchem.2023.107823. Epub 2023 Jan 19.
5
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.
Physiol Rev. 2019 Jan 1;99(1):115-160. doi: 10.1152/physrev.00045.2017.
6
AI-Based Protein Interaction Screening and Identification (AISID).
Int J Mol Sci. 2022 Oct 2;23(19):11685. doi: 10.3390/ijms231911685.
7
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.
J Biol Chem. 2006 May 19;281(20):13964-71. doi: 10.1074/jbc.M601553200. Epub 2006 Mar 17.
9
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily.
Front Immunol. 2023 Mar 27;14:1115667. doi: 10.3389/fimmu.2023.1115667. eCollection 2023.
10
Tumor Necrosis Factor Receptor Superfamily in T Cell Priming and Effector Function.
Adv Immunol. 2018;140:21-57. doi: 10.1016/bs.ai.2018.08.001. Epub 2018 Sep 17.

引用本文的文献

1
Tumor necrosis factor receptor 2 in allergen tolerance: a perspective view.
Front Immunol. 2025 Jun 19;16:1613719. doi: 10.3389/fimmu.2025.1613719. eCollection 2025.
2
CD163, a novel receptor for TNF, was revealed by proximity ligation assay.
Heliyon. 2025 Feb 1;11(3):e42194. doi: 10.1016/j.heliyon.2025.e42194. eCollection 2025 Feb 15.
3
Role of endosomal RANKL-LGR4 signaling during osteoclast differentiation.
J Mol Med (Berl). 2025 Mar;103(3):339-354. doi: 10.1007/s00109-025-02523-2. Epub 2025 Feb 15.
4
The crosstalk between neuropilin-1 and tumor necrosis factor-α in endothelial cells.
Front Cell Dev Biol. 2024 Jun 27;12:1210944. doi: 10.3389/fcell.2024.1210944. eCollection 2024.
5
Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells.
Immunother Adv. 2024 Jun 19;4(1):ltae004. doi: 10.1093/immadv/ltae004. eCollection 2024.
6
Genetically engineered IgG1 and nanobody oligomers acquire strong intrinsic CD40 agonism.
Bioengineered. 2024 Dec;15(1):2302246. doi: 10.1080/21655979.2024.2302246. Epub 2024 Jan 12.
7
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily.
Front Immunol. 2023 Mar 27;14:1115667. doi: 10.3389/fimmu.2023.1115667. eCollection 2023.
8
Bistability regulates TNFR2-mediated survival and death of T-regulatory cells.
J Biol Phys. 2023 Mar;49(1):95-119. doi: 10.1007/s10867-023-09625-3. Epub 2023 Feb 13.
9
Alterations in bone fracture healing associated with TNFRSF signaling pathways.
Front Pharmacol. 2022 Oct 17;13:905535. doi: 10.3389/fphar.2022.905535. eCollection 2022.
10
How does the same ligand activate signaling of different receptors in TNFR superfamily: a computational study.
J Cell Commun Signal. 2023 Sep;17(3):657-671. doi: 10.1007/s12079-022-00701-2. Epub 2022 Sep 28.

本文引用的文献

1
Soluble TL1A is sufficient for activation of death receptor 3.
FEBS J. 2016 Jan;283(2):323-36. doi: 10.1111/febs.13576. Epub 2015 Nov 24.
2
Principles of antibody-mediated TNF receptor activation.
Cell Death Differ. 2015 Nov;22(11):1727-41. doi: 10.1038/cdd.2015.109. Epub 2015 Aug 21.
4
Getting TRAIL back on track for cancer therapy.
Cell Death Differ. 2014 Sep;21(9):1350-64. doi: 10.1038/cdd.2014.81. Epub 2014 Jun 20.
5
HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.
PLoS One. 2014 Feb 28;9(2):e90100. doi: 10.1371/journal.pone.0090100. eCollection 2014.
6
CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants.
Cell Death Dis. 2014 Jan 30;5(1):e1035. doi: 10.1038/cddis.2013.555.
7
Dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction.
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19896-901. doi: 10.1073/pnas.1310838110. Epub 2013 Nov 18.
8
TRAF molecules in cell signaling and in human diseases.
J Mol Signal. 2013 Jun 13;8(1):7. doi: 10.1186/1750-2187-8-7.
9
RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.
Structure. 2012 Nov 7;20(11):1971-82. doi: 10.1016/j.str.2012.08.030. Epub 2012 Oct 2.
10
Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
J Biol Chem. 2012 Jul 6;287(28):24026-42. doi: 10.1074/jbc.M111.328211. Epub 2012 May 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验